MiR-25-3p promotes the expression of fibrosis-related genes in cardiac fibroblasts through BTG2/SOD2 axis
Author:
Affiliation:

1.School of Pharmacy, Southern Medical University, Guangzhou, Guangdong 510515, China;2.School of Medicine, South China University of Technology, Guangzhou, Guangdong 510006, China;3.Guangdong Cardiovascular Institute, Guangzhou, Guangdong 510080, China;4.School of Biology and Biological Engineering, South China University of Technology, Guangzhou, Guangdong 510006, China;5.The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong 510280, China;6.Guangdong Provincial Key Laboratory of Clinical Pharmacology & Guangdong Provincial People’s Hospital & Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, China)

Clc Number:

R329.21;R5

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To investigate the effect of microRNA miR-25-3p on fibrosis-related gene expression in cardiac fibroblasts and mechanism involved. Methods A mouse model of cardiac fibrosis induced by angiotensin Ⅱ (AngⅡ) infusion was constructed, and the differentially expressed miRNAs in the fibrotic mouse myocardium were detected by miRNA chip array. Primary isolation and culture of C57BL/6 mouse cardiac fibroblasts (mCF) were performed, and a cell model of myocardial fibrosis was established based on AngⅡ-treated mCF. The effect of miR-25-3p mimic on the expression of fibrosis-related genes in mCF was studied. The dual luciferase reporter gene assay was performed to verify the binding of miR-25-3p on the 3′-untranslated region (3′UTR) of the B-cell translocation gene 2 (BTG2) gene. Actinomycin D experiment was performed to detect the effect of BTG2 on the stability of superoxide dismutase 2 (SOD2) mRNA in mCF. Results Expression of miR-25-3p was increased in the myocardium of AngⅡ-infused mice and AngⅡ-treated mCF. miR-25-3p could enhance the expression of fibrosis-related genes, including collagen type Ⅰ alpha 1 chain (COL1A1), collagen type Ⅲ alpha 1 chain(COL3A1) and α-smooth muscle actin(α-SMA) in mCF. BTG2 was confirmed to be a target gene of miR-25-3p, and BTG2 mediated the effect of miR-25-3p on promoting fibrosis-related gene expression in mCF. In addition, BTG2 could enhance the expression of SOD2 by increasing the stability of SOD2 mRNA in mCF. Conclusion MiR-25-3p inhibited the level of SOD2 through targeting BTG2 in mCF, resulting in enhancing fibrosis-related gene expression and promoting myocardial fibrosis.

    Reference
    Related
    Cited by
Get Citation

ZHAO Anzhi, GUO Jing, CHEN Liwen, HUANG Zhiqi, CHEN Zerun, ZHU Jiening, ZHANG Mengzhen, ZHANG Ming, XU Jindong, SHAN Zhixin. MiR-25-3p promotes the expression of fibrosis-related genes in cardiac fibroblasts through BTG2/SOD2 axis[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2022,30(4):328-334, 351.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:August 21,2021
  • Revised:November 17,2021
  • Online: March 31,2022
Article QR Code